still own my TBPH from split....I like it just not as much as thrx...strange to see it not follow the huge run in antibiotic stocks....as far as the long run in thrx....patience!! Advairs sales took time to ramp so will BREO!!
100 per month plus 15 dollars per line...let's see for 3 lines...oh have to rent your phone so that's 20 dollars per phone so that's 100+45+60 dollars plus any other BS sprint fees so you are north of $205 per month...what a complete load of TOTAL you know what!!! Bye Bye sprint!!!
August earnings $36 dollars per share following earnings 72$ per share Ask your family doctor about Advair Are you over 18? Oh, We have a much better treatment for You!! It's called BREO!!!
Does anyone have a little fortitude for risk....Just let the data roll out....If we look good on RCC and HCC we will be a 40$ plus company on our own!!!! Quit worrying about a damn buyout!!
Why? Why? Why? would you want a buyout of this company....You should really be hoping that SGEN goes on a buyout spree of it's own to reacquire some of it's drugs.... should immediately move to buyout CLDX...impressive results in triple negative breast cancer and then look to acquire PGNX!!
Hopefully if you are invested here you understand the dynamic between GSK\THRX and their history... I think GSK will be much more inclined to push BREO in asthma, would make next earnings interesting. On the other hand, they could continue to play games and try to suppress THRX share price. In either case if you look at patent expiration at GSK they are playing with a double edged sword. Looking forward to my next $750 payout.
and just to back up the facts over 24 indications being evaluated just by partners....I would keep an eye on CLDX and PGNX.
I personally run a neuroblastoma screen (HPLC/MS) and it is heart breaking to see kids on a daily basis with this disease. It is always comforting to see progress made in cancers that affect children. It's also comforting to know that NB has one of the higher rates of spontaneous remission.
I feel for you I have had to take prednisone several times due to back issues....steroids make me feel terrible hard to complete a full course let alone being on it nonstop.
Depending on how good the RCC data looks we could displace Nexavar in RCC, if this happens we are easily a 20$ stock if we have impressive HCC data then we could also displace nexavar in HCC this would be HUGE!!! Amazingly so....easy 40$+ stock!!